Review



blood germline brca-mutated status testing  (Myriad Genetics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Myriad Genetics blood germline brca-mutated status testing
    Key Randomized Control Trials of Niraparib
    Blood Germline Brca Mutated Status Testing, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blood+germline+brca-mutated+status+testing/blood+germline+brca+mutated+status+testing/pmc11668310-1-9-5
    Average 90 stars, based on 1 article reviews
    blood germline brca-mutated status testing - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Patient Selection for the Use of Niraparib in Advanced Ovarian Cancer: A Review"

    Article Title: Patient Selection for the Use of Niraparib in Advanced Ovarian Cancer: A Review

    Journal: International Journal of Women's Health

    doi: 10.2147/IJWH.S466250

    Key Randomized Control Trials of Niraparib
    Figure Legend Snippet: Key Randomized Control Trials of Niraparib

    Techniques Used: Control, Mutagenesis

    Related Articles

    Control:

    Article Title: Patient Selection for the Use of Niraparib in Advanced Ovarian Cancer: A Review
    Article Snippet: QUADRA , Recurrent EOC , Myriad Genetics – HRD (MyChoice HRD test) Blood germline BRCA-mutated status testing , - HGS histology - 3+ prior lines - measurable disease , 1) Niraparib 300 mg daily x 28 day cycle , OR , OR: gBRCA+ 29% HRD+ 15% HRD- 3% , Niraparib provides OR, which greatest clinical benefit demonstrated in gBRCA+ and HRD+ patients. Of note, they further subdivided patients by platinum-response with graduated response based on platinum-sensitivity..

    Mutagenesis:

    Article Title: Patient Selection for the Use of Niraparib in Advanced Ovarian Cancer: A Review
    Article Snippet: QUADRA , Recurrent EOC , Myriad Genetics – HRD (MyChoice HRD test) Blood germline BRCA-mutated status testing , - HGS histology - 3+ prior lines - measurable disease , 1) Niraparib 300 mg daily x 28 day cycle , OR , OR: gBRCA+ 29% HRD+ 15% HRD- 3% , Niraparib provides OR, which greatest clinical benefit demonstrated in gBRCA+ and HRD+ patients. Of note, they further subdivided patients by platinum-response with graduated response based on platinum-sensitivity..



    Similar Products

    blood germline brca-mutated status testing  (Myriad Genetics)
    90
    Myriad Genetics blood germline brca-mutated status testing
    Key Randomized Control Trials of Niraparib
    Blood Germline Brca Mutated Status Testing, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blood+germline+brca-mutated+status+testing/blood+germline+brca+mutated+status+testing/pmc11668310-1-9-5
    Average 90 stars, based on 1 article reviews
    blood germline brca-mutated status testing - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Key Randomized Control Trials of Niraparib

    Journal: International Journal of Women's Health

    Article Title: Patient Selection for the Use of Niraparib in Advanced Ovarian Cancer: A Review

    doi: 10.2147/IJWH.S466250

    Figure Lengend Snippet: Key Randomized Control Trials of Niraparib

    Article Snippet: QUADRA , Recurrent EOC , Myriad Genetics – HRD (MyChoice HRD test) Blood germline BRCA-mutated status testing , - HGS histology - 3+ prior lines - measurable disease , 1) Niraparib 300 mg daily x 28 day cycle , OR , OR: gBRCA+ 29% HRD+ 15% HRD- 3% , Niraparib provides OR, which greatest clinical benefit demonstrated in gBRCA+ and HRD+ patients. Of note, they further subdivided patients by platinum-response with graduated response based on platinum-sensitivity..

    Techniques: Control, Mutagenesis